NYSEARCA:BOUT Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News $34.51 -0.62 (-1.76%) As of 10:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsBuy This Stock About Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BOUT alerts:Sign Up Key Stats Today's Range$34.57▼$35.1150-Day Range$31.49▼$37.8052-Week Range$31.08▼$42.41Volume521 shsAverage Volume2,247 shsMarket Capitalization$12.08 millionAssets Under Management$12.36 millionDividend Yield0.67%Net Expense Ratio0.85%Aggregate RatingModerate Buy ETF OverviewThe Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.Read More… Innovator IBD Breakout Opportunities ETF ExpensesTypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.80%0.47%0.57%0.52%0.53%Other Expenses0.05%0.39%0.48%0.56%0.51%Total Expense0.85%0.62%0.72%0.73%0.71%Fee Waiver0.00%-0.42%-0.49%-0.65%-0.54%Net Expense0.85%0.53%0.63%0.58%0.60% Receive BOUT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BOUT ETF News HeadlinesBreakout Watch: Top Funds Bet On AI-Fueled Fintech Riding 205% GrowthFebruary 19, 2025 | msn.comBreakout Watch: Some Thought This IPO Was 'Toast' — Then The Tables TurnedFebruary 12, 2025 | msn.comFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousands of smart, forward-thinking individuals are making the move—out of the system and into real, untouchable assets. Because once your funds are frozen, it’s too late.May 22, 2025 | Priority Gold (Ad)Meta Is Just One Of A Huge Barrage Of Breakouts. Here's The Rest.February 5, 2025 | msn.comTrade War In Focus, But Meta Stock Leads This Swarm Of BreakoutsFebruary 5, 2025 | msn.comSelected ETFs To Watch In 2025January 31, 2025 | seekingalpha.comSee More Headlines BOUT ETF - Frequently Asked Questions How have BOUT shares performed this year? Innovator IBD Breakout Opportunities ETF's stock was trading at $39.07 at the start of the year. Since then, BOUT shares have decreased by 11.7% and is now trading at $34.5110. View the best growth stocks for 2025 here. Who are Innovator IBD Breakout Opportunities ETF's major shareholders? Innovator IBD Breakout Opportunities ETF's top institutional shareholders include Comprehensive Money Management Services LLC (8.72%). How do I buy shares of Innovator IBD Breakout Opportunities ETF? Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Innovator IBD Breakout Opportunities ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD Breakout Opportunities ETF investors own include NVIDIA (NVDA), ARK Innovation ETF (ARKK), CRISPR Therapeutics (CRSP), Carvana (CVNA), Fastly (FSLY), Luckin Coffee (LKNCY) and Cloudflare (NET). Fund Details IssuerInnovator Capital Management Fund NameInnovator IBD Breakout Opportunities ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BOUT Inception Date9/13/2018 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkIBD Breakout Stocks Index CategoryBroad Equity FocusStrategy Development LevelDeveloped Markets RegionNorth America Number of Holdings137 Fund Statistics Assets Under Management$12.36 million Average Daily Volume$1,260.40 Discount/Premium-0.17% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorInnovator Capital Management, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest100 shs Miscellaneous Outstanding Shares350,000Beta1.08 Creation Unit50,000 Creation Fee$250.00 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report Top 10 BOUT HoldingsNRG Energy (NYSE:NRG)Holding Weight: 1.52%Nutanix (NASDAQ:NTNX)Holding Weight: 1.50%MasTec (NYSE:MTZ)Holding Weight: 1.47%SLM (NASDAQ:SLM)Holding Weight: 1.43%RBC Bearings (NYSE:RBC)Holding Weight: 1.41%Ferrari N.V.Holding Weight: 1.39%Liberty Live Group (NASDAQ:LLYVK)Holding Weight: 1.39%TechnipFMC (NYSE:FTI)Holding Weight: 1.39%Charles Schwab (NYSE:SCHW)Holding Weight: 1.37%Intuit (NASDAQ:INTU)Holding Weight: 1.36%Full Holdings DetailsBOUT Sector ExposureBOUT Industry Exposure This page (NYSEARCA:BOUT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD Breakout Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD Breakout Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.